# LSM1

## Overview
The LSM1 gene encodes the LSM1 protein, a crucial component of the Lsm1-7 complex, which is involved in the cytoplasmic mRNA decay pathway. This protein complex plays a significant role in post-transcriptional gene regulation by facilitating the degradation of mRNA, thereby influencing mRNA stability and turnover. The LSM1 protein, categorized as an RNA-binding protein, is integral to the formation of processing bodies (P-bodies) and the regulation of mRNA decapping and degradation. It interacts with various decay factors and is essential for the specificity of RNA binding within the complex. The Lsm1-7 complex's ability to bind oligouridylate tracts and its involvement in viral RNA translation further highlight its functional diversity. Alterations in LSM1 expression have been linked to several cancers, underscoring its potential as a biomarker and therapeutic target (Montemayor2020Molecular; Ta2021Potential).

## Structure
The LSM1 protein is a component of the Lsm1-7 complex, which forms a heptameric ring structure similar to the Sm protein ring. This complex is involved in mRNA decay and binds RNA from the 3' end, with its structure being blocked by secondary RNA structures (Montemayor2020Molecular). The Lsm1 protein contains a C-terminal region that influences RNA binding specificity and may act as a gate for RNA threading through the ring (Montemayor2020Molecular). 

The Lsm1-7 complex discriminates against RNAs with a 2',3' cyclic phosphate, which helps avoid certain RNAs in the cytoplasm (Montemayor2020Molecular). The Lsm1 protein's C-terminal helix may need to be removed or displaced for RNA to thread through the ring, suggesting a regulatory role in RNA decay processes (Montemayor2020Molecular). 

The Lsm1-7 complex, including Lsm1, has a preference for binding to oligouridylate tracts, particularly in the presence of Pat1, which enhances its binding affinity (Montemayor2020Molecular). The Lsm1 ∆56C-7 variant, which lacks the last 56 amino acids of Lsm1, shows even higher affinity for RNA, indicating the importance of the C-terminal region in modulating RNA interactions (Montemayor2020Molecular).

## Function
The LSM1 gene encodes a protein that is a component of the Lsm1-7 complex, which plays a crucial role in mRNA decay, a key post-transcriptional mechanism for regulating gene expression. This complex is active in the cytoplasm, where it binds to the 3' end of mRNA, facilitating the recruitment of the protein Pat1 and a decapping enzyme complex. This process leads to the degradation of mRNA by the 5′-3′ exoribonuclease Xrn1, thereby regulating mRNA stability and turnover (Montemayor2020Molecular).

The Lsm1-7 complex also forms processing bodies (P-bodies) and protects mRNA 3′ ends from degradation. It stabilizes specific RNAs during stress conditions and influences the translation of viral RNAs. The Lsm1 subunit is particularly involved in the specificity of RNA binding, with its C-terminal region crucial for the complex's ability to scan RNA (Montemayor2020Molecular). The complex binds tightly to oligouridylate RNAs, and its interaction with RNA is central to its role in mRNA decay (Montemayor2020Molecular). These activities are distinct from those of the Lsm2-8 complex, which is involved in nuclear processes (Montemayor2020Molecular).

## Clinical Significance
Alterations in the expression of the LSM1 gene have been implicated in various cancers. In prostate cancer, LSM1 is downregulated in advanced stages, suggesting its role in cancer progression. The study by Takahashi et al. found that LSM1 mRNA is expressed in normal and organ-confined prostate cancers but not in advanced prostate cancers, indicating that its downregulation is associated with disease advancement (Takahashi2002Downregulation).

In breast cancer, LSM1 is overexpressed and acts as an oncogene. Its high expression is linked to poor prognosis and is associated with advanced tumor stages and worse survival rates. The gene is also involved in pathways related to cytoskeleton remodeling and chemoresistance, highlighting its role in cancer progression and metastasis (NoblejasLópez2021Genomic; Ta2021Potential).

In pancreatic cancer, LSM1, also known as CaSm, contributes to transformation, chemoresistance, and metastasis. Overexpression of LSM1 in pancreatic cancer cells leads to significant tumor progression and metastasis, suggesting its potential as a therapeutic target (Little2016The).

These findings underscore the clinical significance of LSM1 in cancer, where its altered expression can influence disease progression and patient outcomes.

## Interactions
The LSM1 protein is a component of the Lsm1-7 complex, which plays a significant role in mRNA degradation. This complex is involved in the 5'-to-3' mRNA decay pathway, where it activates decapping, a critical step that allows for subsequent exonucleolytic degradation. LSM1 interacts with several decay factors, including Pat1p, Dhh1p, and Xrn1p, as well as mRNPs (messenger ribonucleoproteins) (Chowdhury2007The). The Lsm1-7 complex binds specifically to the 3' UTR of viral RNAs, such as those of the Brome mosaic virus (BMV), which is crucial for the translation and replication of these viral RNAs (Galão2010LSm17).

In yeast, the Lsm1-7 complex preferentially binds U-rich tracts near the 3' end of oligoadenylated mRNA, enhancing RNA binding properties (Garre2018The). The complex's RNA-binding properties are consistent with its in vivo functions, and mutations in the RNA-binding residues of Lsm1p can inhibit mRNA decay (Chowdhury2007The). Structurally, the Lsm1-7 complex forms a closed ring, with Lsm1 interacting with neighboring Lsm proteins, specifically forming hydrogen bonds and van der Waals contacts with Lsm3 and Lsm6 (Zhou2014Crystal). These interactions are crucial for the stability and function of the Lsm1-7 complex.


## References


1. (Montemayor2020Molecular) Molecular basis for the distinct cellular functions of the Lsm1-7 and Lsm2-8 complexes. This article has 1 citations.

[2. (Takahashi2002Downregulation) S Takahashi, S Suzuki, S Inaguma, Y-M Cho, Y Ikeda, N Hayashi, T Inoue, Y Sugimura, N Nishiyama, T Fujita, T Ushijima, and T Shirai. Down-regulation of lsm1 is involved in human prostate cancer progression. British Journal of Cancer, 86(6):940–946, March 2002. URL: http://dx.doi.org/10.1038/sj.bjc.6600163, doi:10.1038/sj.bjc.6600163. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.bjc.6600163)

[3. (Little2016The) E C Little, E R Camp, C Wang, P M Watson, D K Watson, and D J Cole. The casm (lsm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis, 5(1):e182–e182, January 2016. URL: http://dx.doi.org/10.1038/oncsis.2015.45, doi:10.1038/oncsis.2015.45. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/oncsis.2015.45)

[4. (Chowdhury2007The) Ashis Chowdhury, Jaba Mukhopadhyay, and Sundaresan Tharun. The decapping activator lsm1p-7p–pat1p complex has the intrinsic ability to distinguish between oligoadenylated and polyadenylated rnas. RNA, 13(7):998–1016, May 2007. URL: http://dx.doi.org/10.1261/rna.502507, doi:10.1261/rna.502507. This article has 127 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1261/rna.502507)

[5. (Garre2018The) Elena Garre, Vicent Pelechano, Manuel Sánchez del Pino, Paula Alepuz, and Per Sunnerhagen. The lsm1-7/pat1 complex binds to stress-activated mrnas and modulates the response to hyperosmotic shock. PLOS Genetics, 14(7):e1007563, July 2018. URL: http://dx.doi.org/10.1371/journal.pgen.1007563, doi:10.1371/journal.pgen.1007563. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1007563)

[6. (NoblejasLópez2021Genomic) María Noblejas-López, Igor López-Cade, Jesús Fuentes-Antrás, Gonzalo Fernández-Hinojal, Ada Esteban-Sánchez, Aránzazu Manzano, José García-Sáenz, Pedro Pérez-Segura, Miguel la Hoya, Atanasio Pandiella, Balázs Győrffy, Vanesa García-Barberán, and Alberto Ocaña. Genomic mapping of splicing-related genes identify amplifications in lsm1, clns1a, and ilf2 in luminal breast cancer. Cancers, 13(16):4118, August 2021. URL: http://dx.doi.org/10.3390/cancers13164118, doi:10.3390/cancers13164118. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13164118)

[7. (Ta2021Potential) Hoang Dang Khoa Ta, Wei-Jan Wang, Nam Nhut Phan, Nu Thuy An Ton, Gangga Anuraga, Su-Chi Ku, Yung-Fu Wu, Chih-Yang Wang, and Kuen-Haur Lee. Potential therapeutic and prognostic values of lsm family genes in breast cancer. Cancers, 13(19):4902, September 2021. URL: http://dx.doi.org/10.3390/cancers13194902, doi:10.3390/cancers13194902. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13194902)

[8. (Zhou2014Crystal) Lijun Zhou, Yulin Zhou, Jing Hang, Ruixue Wan, Guifeng Lu, Chuangye Yan, and Yigong Shi. Crystal structure and biochemical analysis of the heptameric lsm1-7 complex. Cell Research, 24(4):497–500, February 2014. URL: http://dx.doi.org/10.1038/cr.2014.18, doi:10.1038/cr.2014.18. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2014.18)

[9. (Galão2010LSm17) Rui Pedro Galão, Ashwin Chari, Isabel Alves-Rodrigues, Daniela Lobão, Antonio Mas, Christian Kambach, Utz Fischer, and Juana Díez. Lsm1-7 complexes bind to specific sites in viral rna genomes and regulate their translation and replication. RNA, 16(4):817–827, February 2010. URL: http://dx.doi.org/10.1261/rna.1712910, doi:10.1261/rna.1712910. This article has 40 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1261/rna.1712910)